您当前的位置：
首页 >
文章列表页 >
A Randomized，Double-blind，Multi-center Clinical Trial of Tengfu Jiangya Tablets Combined with Valsartan/Amlodipine in Treatment of Grade 2 Hypertension with Hyperactivity of Liver Yang
更新时间：2024-04-16

    • A Randomized，Double-blind，Multi-center Clinical Trial of Tengfu Jiangya Tablets Combined with Valsartan/Amlodipine in Treatment of Grade 2 Hypertension with Hyperactivity of Liver Yang

      增强出版
    • “The latest research has found that the combination of Tengshu Jiangya tablets and valsartan/amlodipine can effectively reduce blood pressure, improve the compliance rate, improve traditional Chinese medicine syndrome, and ensure clinical safety in the treatment of liver yang hyperactivity syndrome in grade 2 hypertension.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 9, Pages: 83-92(2024)

    • DOI：10.13422/j.cnki.syfjx.20241196    

      CLC： R242;R2-031;R972+.4;R544.1

    • Received：04 September 2023，

      Published Online：07 March 2024，

      Published：05 May 2024

    移动端阅览

  • QI Yuchen,LI Yunlun,WU Yujie,et al.A Randomized，Double-blind，Multi-center Clinical Trial of Tengfu Jiangya Tablets Combined with Valsartan/Amlodipine in Treatment of Grade 2 Hypertension with Hyperactivity of Liver Yang[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(09):83-92. DOI： 10.13422/j.cnki.syfjx.20241196.

  •  
  •  

0

Views

69

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

QI Yuchen
LI Yunlun
WU Yujie
WANG Haiquan
WANG Yu

Related Institution

Shandong University of Traditional Chinese Medicine
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
0